Journal article
Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm
Abstract
BACKGROUND: The aim of this study is to examine the relationship between time in the therapeutic range (TTR) and clinical outcomes in heart failure patients in sinus rhythm treated with warfarin.
METHODS AND RESULTS: We used data from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial to assess the relationship of TTR with the WARCEF primary outcome (ischemic stroke, intracerebral hemorrhage, or death), with death …
Authors
Homma S; Thompson JLP; Qian M; Ye S; Di Tullio MR; Lip GYH; Mann DL; Sacco RL; Levin B; Pullicino PM
Journal
Circulation Heart Failure, Vol. 8, No. 3, pp. 504–509
Publisher
Wolters Kluwer
Publication Date
5 2015
DOI
10.1161/circheartfailure.114.001725
ISSN
1941-3289
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAnticoagulantsAspirinBrain IschemiaCerebral HemorrhageChi-Square DistributionDouble-Blind MethodDrug MonitoringFemaleHeart FailureHeart RateHumansMaleMiddle AgedMultivariate AnalysisPlatelet Aggregation InhibitorsPredictive Value of TestsProportional Hazards ModelsRisk FactorsStrokeStroke VolumeTime FactorsTreatment OutcomeVentricular Function, LeftWarfarin